![]() |
RELATED RESOURCES |
SEC Filings:PHASPHASEBIO PHARMACEUTICALS INC3.89
|
Year | Type ![]() |
![]() |
Period End Date | |
---|---|---|---|---|
2020 | Form 4 | Insider Transaction | 02/14/2020 | 02/12/2020 |
Form SC 13G/A | Beneficial Ownership Statement | 02/14/2020 | N/A | |
Form 8-K* | Current Report* | 02/13/2020 | 02/12/2020 | |
Form 8-K* | Current Report* | 02/11/2020 | 02/11/2020 | |
Form 8-K* | Current Report* | 02/04/2020 | 02/04/2020 | |
Form SC 13G/A | Beneficial Ownership Statement | 01/27/2020 | N/A | |
Form SC 13G/A | Beneficial Ownership Statement | 01/17/2020 | N/A | |
Form 8-K* | Current Report* | 01/13/2020 | 01/09/2020 | |
Form 8-K* | Current Report* | 01/10/2020 | 01/09/2020 | |
Form EFFECT | Notice of Effectiveness | 01/08/2020 | N/A | |
2019 | Form S-3 | Registration statement | 12/27/2019 | N/A |
Form 8-K* | Current Report* | 11/14/2019 | 11/14/2019 | |
Form 10-Q* | Quarterly Report* | 11/14/2019 | 09/30/2019 | |
Form 8-K* | Current Report* | 10/15/2019 | 10/15/2019 | |
Form 3 | Insider Initial Filing | 10/07/2019 | 10/07/2019 |